Kendamil Infant Formula Recalled Over Cereulide Toxin Contamination at Costco
The Canadian Food Inspection Agency has issued an urgent recall for Kendamil brand infant formula with whole milk, specifically targeting products sold online through Costco Canada. This precautionary measure comes after the discovery of potential contamination with cereulide toxin, a dangerous substance produced by certain strains of Bacillus cereus bacteria.
Affected Product Details and Safety Advisory
The recall specifically applies to one-kilogram containers of Kendamil infant formula with whole milk bearing the manufactured date "2025 MA 01" and best before date "2027 MA 01." The affected lot numbers are 897274 and 888632. The CFIA is strongly advising consumers not to consume, use, sell, serve, or distribute these recalled products under any circumstances.
Cereulide toxin presents a significant health risk because it is highly heat stable, meaning normal cooking or formula preparation methods cannot deactivate or destroy it. According to health authorities, symptoms from ingestion typically begin rapidly and most often include nausea and vomiting. The agency emphasizes that while no illnesses have been reported in connection with this specific recall, the potential risk warrants immediate action.
International Trigger and Company Response
This Canadian recall was triggered by a similar action in another country, highlighting the global nature of food safety concerns. Kendal Nutricare Canada, the producer of the affected formula, has provided additional context regarding the contamination source.
The company explained that cereulide has been recently associated with arachidonic acid oil, a source of Omega-6. During a temporary supply disruption, Kendal Nutricare used a different oil supply than usual for the two batches now subject to recall. Importantly, the company maintains that these batches still comply with European safety guidance for cereulide levels in infant formula.
Regulatory Standards and Precautionary Measures
The situation highlights differing regulatory approaches between Health Canada and European authorities. While the affected batches may meet European standards, Health Canada has implemented a more cautious approach, requesting what Kendamil describes as a "precautionary withdrawal" of any batches whose ingredient source could theoretically be impacted.
In their official notice, Kendamil stated: "This is irrespective of lab testing results for the specific batches that demonstrate compliance with strict safety limits set by the scientific community and now being adopted internationally."
Broader Context of Infant Formula Safety
This recall follows similar actions by other major formula manufacturers. Both Nestle and Danone have recently issued baby formula recalls due to possible contamination with the same cereulide toxin, indicating this is not an isolated incident within the industry.
The CFIA continues to monitor the situation and advises consumers who have purchased the affected Kendamil formula to either dispose of it safely or return it to the point of purchase for a full refund. Health authorities recommend that parents and caregivers consult with healthcare providers if they have concerns about their infant's nutrition or potential exposure to contaminated products.
